InsightAce Analytic's most recent study predicts that the market for needle-free injectors will expand with a CAGR of 18.7% over the next five years. Needle-free injectors are an innovative way to introduce various medicines into patients without piercing the skin with a traditional needle. Needle-free injection systems are safer, effective, and more suitable as compared to conventional needles. These systems are available in different forms, such as power sprays, edible products, inhalers, and skin patches. Usage of these injectors can reduce the number of needle stick accidents and associated problems.
The growing demand for self-injection devices, advanced medical infrastructure, growing geriatric population, rising prevalence of chronic and infectious diseases, lack of reusability of traditional needles, increasing healthcare expenditures, and the rising need for vaccination are the major driving factors of the needle-free injectors market. Pharmaceutical companies focus on developing advanced, safe, and pain-free injectors to fulfill the growing demand for self-injection devices. Therefore, launching new quality products in the market is expected to fuel the growth of the needle-free injectors market during the forecast period.
However, the high manufacturing cost of needle-free injections and the lack of trained personnel are likely to limit the market growth during the forecast period 2020-2030.
The needle-free injectors market is classified based on applications, load, technology, end-users, delivery site, usage, and region. The applications segment comprises drug delivery, vaccines, cosmetics, and other applications. The drug delivery segment is expected to dominate this market in the near future due to the rising chronic diseases and geriatric population. By load, the market is segmented into liquid injections, powder injections, projectile injections. The liquid segment is anticipated to hold a significant market share in the coming days due to its rapid administration and flexible nature. By technology, the market is classified into spring-loaded jet injectors, battery-powered jet injectors, gas-powered jet injectors. The market comprises hospitals, veterinary hospitals, specialty clinics, home care settings, and other end-users based on end-users. The market is grouped into intradermal injectors, intramuscular injectors, and subcutaneous injectors in terms of delivery site. The subcutaneous injectors segment is expected to grow rapidly over the forecast years due to its speed and low cost. Based on the usage, the market is segmented into reusable needle-free injectors and disposable needle-free injectors. Geographically, the market is studied across North America, Europe, Asia-Pacific, Latin America, and the Middle East, and Africa.
North America is expected to hold the highest share of this market during the forecast period, followed by Europe due to the high prevalence of chronic diseases and the advancement of medical technologies.
Some of the key players operating in the needle-free injectors market are Pfizer (US), Antares Pharma, Inc. (US), Injex UK (UK), Gaungzhou Medsinglong Medical Equipment Company Ltd. (China), Zogenix (US), D'Antonio Consultants International, Inc. (US), AcuShot Needle Free (Canada), InsuJet (The Netherlands), QS Medical Technology Co., Ltd (China), MIKA MEDICAL CO. (South Korea), and Others.